[SLN] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 15.57%
YoY- 5.50%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 122 122 0 0 0 0 0 -
PBT -6,636 -6,636 -4,799 -4,799 -5,370 -5,370 -4,894 22.43%
Tax 950 950 694 694 507 507 550 43.81%
NP -5,686 -5,686 -4,105 -4,105 -4,862 -4,862 -4,344 19.60%
Tax Rate - - - - - - - -
Total Cost 5,808 5,808 4,105 4,105 4,862 4,862 4,344 21.30%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -4,660.66 -4,660.66 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.22 -0.22 -0.17 -0.17 -0.21 -0.21 -0.19 10.23%
EPS Diluted -0.22 -0.22 -0.17 -0.17 -0.21 -0.21 -0.19 10.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.